CD4 and neoplasm: To examine whether vaccine-induced tumor protection was dependent on CD4+ or CD8+ T cells in the effector phase, we performed in vivo depletion of these two T cell subsets in uniHELP- and neoHELP-immunized mice around the time of MC-38 inoculation (Figures 5D and 5E).